MTOR and neoplasm: It has been shown that incubating UMUC3 cells with increasing concentrations of the mTOR-inhibitor, temsirolimus, over six months does result in resistance, exhibited by reactivated tumor growth and proliferation with mTOR and mTOR-related protein activation [14].